EUCTR2013-003856-19-PL进行中（未招募）1 期
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 2,282
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with asthma who completed the treatment period in a previous dupilumab asthma clinical study (ie, PDY14192, EFC13579 or EFC13691) or patients with asthma who completed the treatment and follow-up periods in previous dupilumab asthma Study DRI12544
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 2135
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 41
排除标准
- •Patients who experienced any hypersensitivity reactions to IMP in the previous dupilumab asthma study, which, in the opinion of the Investigator, could indicate that continued treatment with dupilumab, may present an unreasonable risk for the patient.
研究者
相似试验
进行中（未招募）
1 期
ong-Term Safety Evaluation of Dupilumab in Patients with Asthma (LIBERTY ASTHMA TRAVERSE)MedDRA version: 18.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2013-003856-19-NLSanofi-aventis recherche et développement2,282
进行中（未招募）
1 期
ong-Term Safety Evaluation of Dupilumab in Patients with Asthma (LIBERTY ASTHMA TRAVERSE)MedDRA version: 20.0 Level: PT Classification code 10003553 Term: Asthma System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2013-003856-19-GBSanofi-aventis recherche et développement2,206
招募中
4 期
Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Mexiletine in Paediatric Patients with Myotonic Disorders Who Have Completed MEX-NM-301.2024-513484-89-00Lupin Europe GmbH12
进行中（未招募）
1 期
ong-Term Safety Evaluation of Dupilumab in Patients with Asthma (LIBERTY ASTHMA TRAVERSE)AsthmaEUCTR2013-003856-19-DKSanofi-aventis recherche et développement2,206
进行中（未招募）
1 期
ong-Term Safety Evaluation of Dupilumab in Patients with Asthma (LIBERTY ASTHMA TRAVERSE)AsthmaEUCTR2013-003856-19-HUSanofi-aventis recherche et développement2,206